Skip to search formSkip to main contentSkip to account menu

GSK1265744

Known as: GSK744 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
ABSTRACT GSK1265744 is a new HIV integrase strand transfer inhibitor (INSTI) engineered to deliver efficient antiviral activity… 
Highly Cited
2014
Highly Cited
2014
Background:GSK1265744 (744) is an HIV-1 integrase inhibitor in clinical development as a long-acting (LA) injectable formulation… 
Highly Cited
2014
Highly Cited
2014
Objective:Pharmacokinetics, safety, and tolerability of GSK1265744 (744) and rilpivirine (RPV) (TMC278) were assessed after… 
Highly Cited
2013
Highly Cited
2013
We report herein the discovery of the human immunodeficiency virus type-1 (HIV-1) integrase inhibitors dolutegravir (S/GSK1349572… 
Highly Cited
2013
Highly Cited
2013
Abstract Background: GSK1265744 is an HIV integrase strand transfer inhibitor selected for clinical development. Objective: This… 
Review
2013
Review
2013
Purpose of reviewLong-acting antiretroviral (ARV) drugs may improve adherence to therapy and extend opportunities for therapeutic… 
Highly Cited
2013
Highly Cited
2013
ABSTRACT Dolutegravir (DTG) and GSK1265744 are HIV integrase inhibitors (INIs) in clinical development. The oral formulation of…